Rigor, reproducibility, and in vitro cerebrospinal fluid assays: The devil in the details
- PMID: 28440033
- PMCID: PMC5639705
- DOI: 10.1002/ana.24940
Rigor, reproducibility, and in vitro cerebrospinal fluid assays: The devil in the details
Abstract
Divergent results and misinterpretation of non-significant findings remain problematic in science – especially in retrospective, hypothesis generating, translational research. When such divergence occurs, it is imperative that the cause of the divergence be established.
In their recent paper in Annals of Neurology, Dauvilliers et al challenged our earlier finding that cerebrospinal fluid (CSF) from some patients with unexplained excessive daytime sleepiness enhances the activation of GABAA receptors (GABAA-R). They present data from 15 subjects in which they were unable to find evidence of enhanced activation of GABAA receptors. Here we: 1) establish how flaws in Dauvilliers’ experimental design account for this difference; 2) present new data demonstrating the robustness and reproducibility of our methods and 3) summarize the clinical promise of GABAA-R antagonism in treating IH and related disorders.
Conflict of interest statement
Nothing to disclose for this work (see ICJME for interests not related to the current work): OAM, ST, MAJ, AFF, DB, LMT, EMH, NF, PS, PSG & JWL AJ, OAM, DBR, JWL and LMT contributed to the conception and design of the study. OAM, ST, MAJ, AFF, AJ, PS, EMH, NF and BC were responsible for acquisition and analysis of the data. AJ, MAJ, OAM, LMT, PSG, JWL, DBR and DB were responsible for drafting the text or preparing the figures.
Figures
Comment in
-
Reply to "Rigor, reproducibility and in vitro CSF assays: The devil in the details".Ann Neurol. 2017 Jun;81(6):907-910. doi: 10.1002/ana.24939. Epub 2017 Jun 2. Ann Neurol. 2017. PMID: 28439988 No abstract available.
Comment on
-
Absence of γ-aminobutyric acid-a receptor potentiation in central hypersomnolence disorders.Ann Neurol. 2016 Aug;80(2):259-68. doi: 10.1002/ana.24710. Epub 2016 Jul 14. Ann Neurol. 2016. PMID: 27315195
References
-
- Dauvilliers Y, Evangelista E, Lopez R, et al. Absence of gamma-aminobutyric acid-a receptor potentiation in central hypersomnolence disorders. Annals of neurology. 2016;80:259–268. - PubMed
-
- Rye DB, Bliwise DL, Parker K, et al. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Sci Transl Med. 2012;4:161ra151. - PubMed
-
- Balansa W, Islam R, Fontaine F, et al. Sesterterpene glycinyl-lactams: a new class of glycine receptor modulator from Australian marine sponges of the genus Psammocinia. Org Biomol Chem. 2013;11:4695–4701. - PubMed
-
- Billiard M, Sonka K. Idiopathic hypersomnia. Sleep Med Rev. 2016;29:23–33. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
